Scilex Holding Company (NASDAQ:SCLX) does about 1.53M shares in volume on a normal day but saw 2742245 shares change hands in the recent trading day. The company now has a market cap of 85.16M USD. Its current market price is $0.35, marking an increase of 0.98% compared to the previous close of $0.35. The 52 week high reached by this stock is $2.30 whilst the lowest price level in 52 weeks is $0.21.
Scilex Holding Company (SCLX) has a 20-day trading average at $0.3184 and the current price is -84.78% off the 52-week high compared with 66.67% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3880 and its 200-day simple moving average is $0.9449. If we look at the stock’s price movements over the week, volatility stands at 13.77%, which decreases to 10.93% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 51.61 to suggest the stock is neutral.
The consensus objective for the share price is $11.85, suggesting that the stock has a potential upside of 97.05% over the period.
FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 2 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on January 27, 2025 when D. Boral Capital initiated the stock to “Buy” and issued a price target of $22. Rodman & Renshaw initiated its price target at $13.
The current price level is 9.92%, -9.80%, and -62.96% away from its SMA20, SMA50, and SMA200 respectively, with the SCLX price moving above the 50-day SMA on current market day. Scilex Holding Company (SCLX) stock is up 20.11% over the week and -4.48% over the past month. Its price is -17.92% year-to-date and -74.26% over the past year.
To reach the target analysts have set, the stock logically needs to grow 97.05 percent from here.
Outstanding shares total 243.31M with insiders holding 25.96% of the shares and institutional holders owning 20.34% of the company’s common stock. The forward price to earnings ratio is 5.25. The beta has a value of 0.94. Price to sales ratio is 1.54.
